论文部分内容阅读
对静注丙种球蛋白(IVIG)治疗呼吸道合胞病毒(RSV)肺炎的患儿进行了3年随访,并与对照组比较。结果显示IVIG可显著降低RSV肺炎患儿病后呼吸道感染和反复喘息的次数以及哮喘的发病率、患儿病后免疫紊乱的程度也有所减轻。表明IVIG对治疗RSV肺炎有较好的远期疗效。
Three-year follow-up was performed on children with intravenous gamma globulin (IVIG) for the treatment of respiratory syncytial virus (RSV) pneumonia and compared with the control group. The results showed that IVIG significantly reduced the number of respiratory infections and recurrent wheezing in children with RSV pneumonia and the incidence of asthma in children with RSV. The degree of immune disorder in children with RSV was also reduced. It shows that IVIG has better long-term curative effect in treating RSV pneumonia.